To evaluate a proof-of-principle screen for identifying drugs with the potential to increase B7-H3 expression on lung metastatic (LM7) osteosarcoma cells, we developed an immunofluorescence-based high-content assay to measure endogenous B7-H3 protein expression on the surface of single cells. The gene discussed is CD276; the disease is osteosarcoma.